Arrowpoint Investment Partners (Singapore) Pte. Ltd.
Position in UTHR — UNITED THERAPEUTICS Corp
CIK 2032331
SINGAPORE, U0
Position in UTHR
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$312,500
+$312,500 QoQ
Shares Held
527
Ownership
0.001%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Derivatives in UTHR
reported options exposure · as of Sep 30, 2025CallValue
$1,048,025
CallShares
2,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Arrowpoint Investment Partners (Singapore) Pte. Ltd. holds $4,293,255 across 4 Drug Manufacturers - Specialty & Generic names. UTHR ranks #4 (7.3% of the industry book) .
All Filings in UTHR
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $312,500 | 527 | Shares | Defined | 2026-05-14 | |
| 2025-09-30 | $1,048,025 | 2,500 | Call | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||